FDA Adverse Event Malfunction Summary report: N

OPTI SARA-COV-2 RT-PCR

MDR report key: 11988725 · Received June 12, 2021

Report

Report Number
3004102403-2021-00002
Event Type
Malfunction
Date Received
June 12, 2021
Date of Event
May 1, 2021
Report Date
June 12, 2021
Manufacturer
OPTI MEDICAL SYSTEMS, INC.
Product Code
QJR
PMA / PMN Number
EUA200215
Removal / Correction Number
Z-2310-2021
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

OPTI MEDICAL SYSTEMS SENT A NOTICE TO CUSTOMERS BASED ON DISCUSSIONS WITH FDA INDICATING THAT USERS OF OPTI SARS-COV-2 RT PCR TEST THAT A CENTRIFUGATION STEP IS NECESSARY TO PREVENT FALSE POSITIVIES WHEN USING OUR PCR TEST.

Description of Event or Problem · 0

OF THE 21 POSITIVE SAMPLES CORRELATES 100% WITH PREVIOUS RESULTS. OUT OF 19 NEGATIVE PATIENT'S SAMPLES, 2 SAMPLES CAME OUT POSITIVES WITH HIGH CT VALUES (36.0 AND 41.84 RESPECTIVELY). AN EXPLANATION OF ONE OF THE DISCREPANCIES, THE ONE WITH THE HIGH CT VALUE COULD BE A CONTAMINATION ISSUE. THE DISCREPANCIES OBTAINED WHEN VALIDATING THIS ASSAY CAN DEPEND ON THE SENSITIVITY OF EACH METHODOLOGY, THE PLATFORM USED AND THE REAGENTS USED TO TEST THESE SAMPLES.

Description of Event or Problem · 1

OF THE 21 POSITIVE SAMPLES CORRELATES 100% WITH PREVIOUS RESULTS. OUT OF 19 NEGATIVE PATIENT'S SAMPLES, 2 SAMPLES CAME OUT POSITIVES WITH HIGH CT VALUES (36.0 AND 41.84 RESPECTIVELY). AN EXPLANATION OF ONE OF THE DISCREPANCIES, THE ONE WITH THE HIGH CT VALUE COULD BE A CONTAMINATION ISSUE. THE DISCREPANCIES OBTAINED WHEN VALIDATING THIS ASSAY CAN DEPEND ON THE SENSITIVITY OF EACH METHODOLOGY, THE PLATFORM USED AND THE REAGENTS USED TO TEST THESE SAMPLES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
885203 OPTI SARA-COV-2 RT-PCR COVID 19 MOLECULAR DIAGNOSTIC TEST QJR OPTI MEDICAL SYSTEMS, INC. 99-57003

Patients

Seq Age Sex Outcome Treatment
1